IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran, H Ikeda, AT Bruce, JM White… - Nature, 2001 - nature.com
Lymphocytes were originally thought to form the basis of a 'cancer immunosurveillance'
process that protects immunocompetent hosts against primary tumour development,, but this …
process that protects immunocompetent hosts against primary tumour development,, but this …
[PDF][PDF] Vijay Shankaran*, Hiroaki Ikeda*, Allen T. Bruce*, J. Michael White
PE Swanson, LJ Old, RD Schreiber - immunity, 1999 - thelundlab.com
Lymphocytes were originally thought to form the basis of acancer immunosurveillance'
process that protects immunocompetent hosts against primary tumour development1, 2, but …
process that protects immunocompetent hosts against primary tumour development1, 2, but …
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran, H Ikeda, AT Bruce, JM White… - Nature, 2001 - econpapers.repec.org
Lymphocytes were originally thought to form the basis of a 'cancer immunosurveillance'
process that protects immunocompetent hosts against primary tumour development1, 2, but …
process that protects immunocompetent hosts against primary tumour development1, 2, but …
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran, H Ikeda, AT Bruce, JM White… - Nature, 2001 - ideas.repec.org
Lymphocytes were originally thought to form the basis of a 'cancer immunosurveillance'
process that protects immunocompetent hosts against primary tumour development1, 2, but …
process that protects immunocompetent hosts against primary tumour development1, 2, but …
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.
V Shankaran, H Ikeda, AT Bruce, JM White… - …, 2001 - search.ebscohost.com
Shows that lymphocytes and IFN... collaborate to protect against the development of
carcinogen-induced sarcomas and spontaneous epithelial carcinomas. Assessment of the …
carcinogen-induced sarcomas and spontaneous epithelial carcinomas. Assessment of the …
[引用][C] IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V SHANKARAN, H IKEDA, AT BRUCE… - Nature …, 2001 - pascal-francis.inist.fr
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran, H Ikeda, AT Bruce, JM White… - Nature, 2001 - profiles.wustl.edu
Lymphocytes were originally thought to form the basis of a'cancer immunosurveillance'
process that protects immunocompetent hosts against primary tumour development 1, 2, but …
process that protects immunocompetent hosts against primary tumour development 1, 2, but …
[引用][C] IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran, H Ikeda, AT Bruce, JM White… - Nature, 2001 - cir.nii.ac.jp
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF][PDF] Vijay Shankaran*, Hiroaki Ikeda*, Allen T. Bruce*, J. Michael White
PE Swanson, LJ Old, RD Schreiber - immunity, 1999 - moodlearchive.epfl.ch
Lymphocytes were originally thought to form the basis of acancer immunosurveillance'
process that protects immunocompetent hosts against primary tumour development1, 2, but …
process that protects immunocompetent hosts against primary tumour development1, 2, but …
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran, H Ikeda, AT Bruce, JM White… - …, 2001 - ui.adsabs.harvard.edu
Lymphocytes were originally thought to form the basis of acancer immunosurveillance'
process that protects immunocompetent hosts against primary tumour development 1, 2, but …
process that protects immunocompetent hosts against primary tumour development 1, 2, but …